RATIONALE: Decision-making involves two fundamental axes of control namely valence, spanning reward and punishment, and action, spanning invigoration and inhibition. We recently exploited a go/no-go task whose contingencies explicitly decouple valence and action to show that these axes are inextricably coupled during learning. This results in a disadvantage in learning to go to avoid punishment and in learning to no-go to obtain a reward. The neuromodulators dopamine and serotonin are likely to play a role in these asymmetries: Dopamine signals anticipation of future rewards and is also involved in an invigoration of motor responses leading to reward, but it also arbitrates between different forms of control. Conversely, serotonin is implicated in motor inhibition and punishment processing. OBJECTIVE: To investigate the role of dopamine and serotonin in the interaction between action and valence during learning.Methods We combined computational modeling with pharmacological manipulation in 90 healthy human volunteers, using levodopa and citalopram to affect dopamine and serotonin, respectively. RESULTS: We found that, after administration of levodopa,action learning was less affected by outcome valence when compared with the placebo and citalopram groups. This highlights in this context a predominant effect of levodopa in controlling the balance between different forms of control.Citalopram had distinct effects, increasing participants'tendency to perform active responses independent of outcome valence, consistent with a role in decreasing motor inhibition. CONCLUSIONS: Our findings highlight the rich complexities of the roles played by dopamine and serotonin during instrumental learning.
RATIONALE: Decision-making involves two fundamental axes of control namely valence, spanning reward and punishment, and action, spanning invigoration and inhibition. We recently exploited a go/no-go task whose contingencies explicitly decouple valence and action to show that these axes are inextricably coupled during learning. This results in a disadvantage in learning to go to avoid punishment and in learning to no-go to obtain a reward. The neuromodulators dopamine and serotonin are likely to play a role in these asymmetries: Dopamine signals anticipation of future rewards and is also involved in an invigoration of motor responses leading to reward, but it also arbitrates between different forms of control. Conversely, serotonin is implicated in motor inhibition and punishment processing. OBJECTIVE: To investigate the role of dopamine and serotonin in the interaction between action and valence during learning.Methods We combined computational modeling with pharmacological manipulation in 90 healthy human volunteers, using levodopa and citalopram to affect dopamine and serotonin, respectively. RESULTS: We found that, after administration of levodopa,action learning was less affected by outcome valence when compared with the placebo and citalopram groups. This highlights in this context a predominant effect of levodopa in controlling the balance between different forms of control.Citalopram had distinct effects, increasing participants'tendency to perform active responses independent of outcome valence, consistent with a role in decreasing motor inhibition. CONCLUSIONS: Our findings highlight the rich complexities of the roles played by dopamine and serotonin during instrumental learning.
Authors: Shelly B Flagel; Jeremy J Clark; Terry E Robinson; Leah Mayo; Alayna Czuj; Ingo Willuhn; Christina A Akers; Sarah M Clinton; Paul E M Phillips; Huda Akil Journal: Nature Date: 2010-12-08 Impact factor: 49.962
Authors: Quentin J M Huys; Roshan Cools; Martin Gölzer; Eva Friedel; Andreas Heinz; Raymond J Dolan; Peter Dayan Journal: PLoS Comput Biol Date: 2011-04-21 Impact factor: 4.475
Authors: Jennifer C Swart; Monja I Froböse; Jennifer L Cook; Dirk Em Geurts; Michael J Frank; Roshan Cools; Hanneke Em den Ouden Journal: Elife Date: 2017-05-15 Impact factor: 8.140
Authors: Nelleke C Van Wouwe; Daniel O Claassen; Joseph S Neimat; Kristen E Kanoff; Scott A Wylie Journal: J Cogn Neurosci Date: 2017-01-27 Impact factor: 3.225
Authors: Benjamín Garzón; Martin Lövdén; Lieke de Boer; Jan Axelsson; Katrine Riklund; Lars Bäckman; Lars Nyberg; Marc Guitart-Masip Journal: Brain Struct Funct Date: 2021-01-09 Impact factor: 3.270
Authors: Heather E Webber; Paula Lopez-Gamundi; Sydney N Stamatovich; Harriet de Wit; Margaret C Wardle Journal: Neurosci Biobehav Rev Date: 2020-11-14 Impact factor: 8.989
Authors: Rick A Adams; Michael Moutoussis; Matthew M Nour; Tarik Dahoun; Declan Lewis; Benjamin Illingworth; Mattia Veronese; Christoph Mathys; Lieke de Boer; Marc Guitart-Masip; Karl J Friston; Oliver D Howes; Jonathan P Roiser Journal: Cereb Cortex Date: 2020-05-18 Impact factor: 5.357